Alzheimer's Society comment: New Alzheimer's drug research
Date published:
Wednesday, April 15, 2009News source:
Alzheimer’s Society Region:
International Featured item on home page:
no
New research suggests that the drug CPHPC successfully interferes with the build up of Amyloid in the brains of people with Alzheimer’s and does not have side effects.
The University College London (UCL) research will be published in Proceedings of the National Academy of Sciences.
Dr Susanne Sorensen
Head of Research
Alzheimer's Society
'A key characteristic of Alzheimer's disease is the clumping together of proteins in the brain. It's very exciting that this drug could potentially interfere with this process, but it's too early to say how much it will benefit people with the disease.
This research is an important step forward because it shows the drug is safe to use in people with Alzheimer's. It provides a green flag for longer and larger studies to investigate if this drug can treat the symptoms, or even slow the progression of this devastating disease. One million people will develop dementia in the next 10 years. We must act now to improve care for today and find a cure for tomorrow.'
Dr Susanne Sorensen
Head of Research
Alzheimer's Society
Similar entries
- Alzheimer's Society comment on the Etanercept drug treatment
- Delayed ageing linked to Alzheimer's in mice
- Alzheimer's Society comment on new research into heart rhythm disorder as a risk factor for dementia
- Alzheimer's Society comment on benefits of weekly curry
- Alzheimer's Society comment on research that genes in early onset are associated with memory
- Alzheimer's Society comment on Alzheimer's Disease International's report on the prevalence of dementia worldwide
- New Flurizan trial suggests drug benefits people in the early stages of Alzheimer’s
- Alzheimer’s Society comment on new research investigating link between Alzheimer’s and Epilepsy
- Alzheimer’s comment on research that cognitive activities delay onset of memory decline in persons who develop dementia
- Research adds weight to new thinking on Alzheimer's disease: Alzheimer's Society UK
